Loading company…
Mesh Bio provides digital health analytics and decision support for healthcare providers.
Founded in 2018 and based in Singapore, Mesh Bio offers a Health Intelligence Platform using systems biology and predictive analytics to support clinical decisions and chronic disease management. Its tools provide workflow automation, risk predictions, and patient insights. In January 2024, it raised Series A funding led by East Ventures, with elev8.vc and SEEDS Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in